Cardio Diagnostics Holdings, Inc. (CDIO) SEC Filings & Financial Intelligence
Cardio Diagnostics Holdings, Inc. (CDIO) is a publicly traded company on the Nasdaq, categorized under SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CDIO
CIK: 1870144
Exchange: Nasdaq
SIC 2835: In Vitro & In Vivo Diagnostic Substances
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Prager Metis CPAs, LLC
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerJie Bai
Audit LocationHackensack, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-09-30 | PRIMARY DOCUMENT | 0002055040-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | PRIMARY DOCUMENT | 0002060369-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | PRIMARY DOCUMENT | 0001950394-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | PRIMARY DOCUMENT | 0002006956-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-09-18 | 2026-09-18 | FORM 8-K | 0001553350-26-000131 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-08 | — | DEFINITIVE 14A ADDITIONAL MATERIALS | 0001079973-26-001223 | View SEC Doc Filr Page |
| 8-K | 2026-08-20 | 2026-08-20 | FORM 8-K | 0001079973-26-001153 | View SEC Doc Filr Page |
| 10-Q | 2026-08-07 | 2026-06-30 | QUARTERLY REPORT | 0001079973-26-001016 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-07 | — | DEFINITIVE 14A ADDITIONAL MATERIALS | 0001079973-26-001010 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-05 | 2026-09-18 | DEFINITIVE 14A | 0001079973-26-001003 | View SEC Doc Filr Page |
| ARS | 2026-07-23 | 2025-12-31 | ANNUAL REPORT TO SECURITY HOLDERS | 0001079973-26-000965 | View SEC Doc Filr Page |
| PRE 14A | 2026-07-13 | 2026-09-18 | PRELIMINARY 14A | 0001079973-26-000945 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | PRIMARY DOCUMENT | 0002060369-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | PRIMARY DOCUMENT | 0002055040-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | PRIMARY DOCUMENT | 0001950394-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | PRIMARY DOCUMENT | 0002006956-26-000003 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | QUARTERLY REPORT | 0001553350-26-000089 | View SEC Doc Filr Page |
| 4 | 2026-04-02 | 2026-03-31 | PRIMARY DOCUMENT | 0002060369-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-04-02 | 2026-03-31 | PRIMARY DOCUMENT | 0002055040-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-04-02 | 2026-03-31 | PRIMARY DOCUMENT | 0001950394-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-04-02 | 2026-03-31 | PRIMARY DOCUMENT | 0002006956-26-000002 | View SEC Doc Filr Page |
| 10-K | 2026-03-13 | 2025-12-31 | ANNUAL REPORT | 0001553350-26-000023 | View SEC Doc Filr Page |
| 8-K | 2026-02-19 | 2026-02-19 | FORM 8-K | 0001079973-26-000239 | View SEC Doc Filr Page |
| 4 | 2026-01-06 | 2025-12-31 | PRIMARY DOCUMENT | 0002060369-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-01-06 | 2025-12-31 | PRIMARY DOCUMENT | 0002055040-26-000001 | View SEC Doc Filr Page |